Phenomix Sciences, Inc. — Form D
Phenomix Sciences, Inc. of MENLO PARK, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-02-22. The offering totals $5.0M, of which $1.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2023-02-22
- Form: D
- Accession: 0001966746-23-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $1.0M
- Remaining: $4.0M
- Investors: 3
- Date of first sale: 2023-02-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-474031
Issuer
- Name: Phenomix Sciences, Inc.
- CIK: 0001966746
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 3000 SAND HILL RD., MENLO PARK, CA, 94025
- Phone: 612.270.2015
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Mark Bagnall | Director | Menlo Park, CA |
| Lawrence K Cohen | Director | Menlo Park, CA |
| Karl K Ronn | Director | Menlo Park, CA |
| Mark Bagnall | Executive Officer | Menlo Park, CA |
| Lawrence Cohen | Director | Menlo Park, CA |
| Andres Acosta | Director | Menlo Park, CA |
| Mark Bengall | Director | Menlo Park, CA |
| Mark Bengall | Executive Officer | Menlo Park, CA |
| Michael Camilleri | Director | Menlo Park, CA |
| Karl Ronn | Director | Los Gatos, CA |
Other filings by this issuer (2)
More